Index of reports
> Cases with Hypotension (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bumex (Bumetanide) where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Bumex side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-26
Patient: male
Reactions: Hypotension, Procedural Complication
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Placebo
Dosage: (df)
Indication: Type 2 Diabetes Mellitus
Start date: 2011-03-15
Saxagliptin
Dosage: (df)
Indication: Type 2 Diabetes Mellitus
Start date: 2011-03-15
Humalog
Dosage: (df)
Indication: Type 2 Diabetes Mellitus
Bumex
Dosage: (df)
Other drugs received by patient: Anti-Coagulants (Unknown); Statin (Unknown); Ezetimibe (Unknown); Diuretics (Unknown); Alpha Blockers; Other Anti-Platelet Agents (Unknown); Angiotensin Converting Enzyme Inhibitor; Beta-Blocker; Aspirin
Possible Bumex side effects in male
Reported by a physician from United States on 2012-03-23
Patient: male, weighing 87.3 kg (192.1 pounds)
Reactions: Dehydration, Hypotension, Enterocolitis Infectious
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Enalapril Maleate
Dosage: unk
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2012-02-16
End date: 2012-03-05
Spironolactone
Dosage: 50 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Start date: 2006-12-15
Spironolactone
Indication: Hypertension
Coreg
Dosage: 3.125 mg, bid
Administration route: Oral
Indication: Cardiac Failure Congestive
Start date: 2012-01-11
Bumex
Indication: Hypertension
Blinded NO Treatment Received
Dosage: unk
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2012-02-16
End date: 2012-03-05
Valsartan
Dosage: unk
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2012-02-16
End date: 2012-03-05
Bumex
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-12-20
Other drugs received by patient: Aspirin
|